Matches in SemOpenAlex for { <https://semopenalex.org/work/W2921476261> ?p ?o ?g. }
- W2921476261 endingPage "2828" @default.
- W2921476261 startingPage "2819" @default.
- W2921476261 abstract "The efficacy of ticagrelor in the long-term post–ST-segment elevation myocardial infarction (STEMI) treated with fibrinolytic therapy remains uncertain. The purpose of this study was to evaluate the efficacy of ticagrelor when compared with clopidogrel in STEMI patients treated with fibrinolytic therapy. This international, multicenter, randomized, open-label with blinded endpoint adjudication trial enrolled 3,799 patients (age <75 years) with STEMI receiving fibrinolytic therapy. Patients were randomized to ticagrelor (180-mg loading dose, 90 mg twice daily thereafter) or clopidogrel (300- to 600-mg loading dose, 75 mg daily thereafter). The key outcomes were cardiovascular mortality, myocardial infarction, or stroke, and the same composite outcome with the addition of severe recurrent ischemia, transient ischemic attack, or other arterial thrombotic events at 12 months. The combined outcome of cardiovascular mortality, myocardial infarction, or stroke occurred in 129 of 1,913 patients (6.7%) receiving ticagrelor and in 137 of 1,886 patients (7.3%) receiving clopidogrel (hazard ratio: 0.93; 95% confidence interval: 0.73 to 1.18; p = 0.53). The composite of cardiovascular mortality, myocardial infarction, stroke, severe recurrent ischemia, transient ischemic attack, or other arterial thrombotic events occurred in 153 of 1,913 patients (8.0%) treated with ticagrelor and in 171 of 1,886 patients (9.1%) receiving clopidogrel (hazard ratio: 0.88; 95% confidence interval: 0.71 to 1.09; p = 0.25). The rates of major, fatal, and intracranial bleeding were similar between the ticagrelor and clopidogrel groups. Among patients age <75 years with STEMI, administration of ticagrelor after fibrinolytic therapy did not significantly reduce the frequency of cardiovascular events when compared with clopidogrel. (Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis [TREAT]; NCT02298088)" @default.
- W2921476261 created "2019-03-22" @default.
- W2921476261 creator A5003410400 @default.
- W2921476261 creator A5008461772 @default.
- W2921476261 creator A5010466306 @default.
- W2921476261 creator A5011058924 @default.
- W2921476261 creator A5014449865 @default.
- W2921476261 creator A5017390449 @default.
- W2921476261 creator A5026270125 @default.
- W2921476261 creator A5026937673 @default.
- W2921476261 creator A5028707595 @default.
- W2921476261 creator A5033773108 @default.
- W2921476261 creator A5047187243 @default.
- W2921476261 creator A5055849986 @default.
- W2921476261 creator A5057190625 @default.
- W2921476261 creator A5058376486 @default.
- W2921476261 creator A5059003763 @default.
- W2921476261 creator A5062843291 @default.
- W2921476261 creator A5065798184 @default.
- W2921476261 creator A5066263534 @default.
- W2921476261 creator A5066844424 @default.
- W2921476261 creator A5067237537 @default.
- W2921476261 creator A5075104295 @default.
- W2921476261 creator A5079011554 @default.
- W2921476261 creator A5083953719 @default.
- W2921476261 date "2019-06-01" @default.
- W2921476261 modified "2023-10-17" @default.
- W2921476261 title "Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis" @default.
- W2921476261 cites W1969211460 @default.
- W2921476261 cites W1992298417 @default.
- W2921476261 cites W2001688139 @default.
- W2921476261 cites W2024656127 @default.
- W2921476261 cites W2043964965 @default.
- W2921476261 cites W2058619539 @default.
- W2921476261 cites W2107797912 @default.
- W2921476261 cites W2140501627 @default.
- W2921476261 cites W2163050713 @default.
- W2921476261 cites W2295175909 @default.
- W2921476261 cites W2331820709 @default.
- W2921476261 cites W2737845351 @default.
- W2921476261 cites W2752033985 @default.
- W2921476261 cites W2754054868 @default.
- W2921476261 cites W2770523298 @default.
- W2921476261 cites W2791645311 @default.
- W2921476261 cites W2793325200 @default.
- W2921476261 cites W2809434376 @default.
- W2921476261 cites W2887342090 @default.
- W2921476261 doi "https://doi.org/10.1016/j.jacc.2019.03.011" @default.
- W2921476261 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30898608" @default.
- W2921476261 hasPublicationYear "2019" @default.
- W2921476261 type Work @default.
- W2921476261 sameAs 2921476261 @default.
- W2921476261 citedByCount "54" @default.
- W2921476261 countsByYear W29214762612019 @default.
- W2921476261 countsByYear W29214762612020 @default.
- W2921476261 countsByYear W29214762612021 @default.
- W2921476261 countsByYear W29214762612022 @default.
- W2921476261 countsByYear W29214762612023 @default.
- W2921476261 crossrefType "journal-article" @default.
- W2921476261 hasAuthorship W2921476261A5003410400 @default.
- W2921476261 hasAuthorship W2921476261A5008461772 @default.
- W2921476261 hasAuthorship W2921476261A5010466306 @default.
- W2921476261 hasAuthorship W2921476261A5011058924 @default.
- W2921476261 hasAuthorship W2921476261A5014449865 @default.
- W2921476261 hasAuthorship W2921476261A5017390449 @default.
- W2921476261 hasAuthorship W2921476261A5026270125 @default.
- W2921476261 hasAuthorship W2921476261A5026937673 @default.
- W2921476261 hasAuthorship W2921476261A5028707595 @default.
- W2921476261 hasAuthorship W2921476261A5033773108 @default.
- W2921476261 hasAuthorship W2921476261A5047187243 @default.
- W2921476261 hasAuthorship W2921476261A5055849986 @default.
- W2921476261 hasAuthorship W2921476261A5057190625 @default.
- W2921476261 hasAuthorship W2921476261A5058376486 @default.
- W2921476261 hasAuthorship W2921476261A5059003763 @default.
- W2921476261 hasAuthorship W2921476261A5062843291 @default.
- W2921476261 hasAuthorship W2921476261A5065798184 @default.
- W2921476261 hasAuthorship W2921476261A5066263534 @default.
- W2921476261 hasAuthorship W2921476261A5066844424 @default.
- W2921476261 hasAuthorship W2921476261A5067237537 @default.
- W2921476261 hasAuthorship W2921476261A5075104295 @default.
- W2921476261 hasAuthorship W2921476261A5079011554 @default.
- W2921476261 hasAuthorship W2921476261A5083953719 @default.
- W2921476261 hasBestOaLocation W29214762611 @default.
- W2921476261 hasConcept C126322002 @default.
- W2921476261 hasConcept C127413603 @default.
- W2921476261 hasConcept C164705383 @default.
- W2921476261 hasConcept C207103383 @default.
- W2921476261 hasConcept C2777849778 @default.
- W2921476261 hasConcept C2780645631 @default.
- W2921476261 hasConcept C2780890252 @default.
- W2921476261 hasConcept C44249647 @default.
- W2921476261 hasConcept C500558357 @default.
- W2921476261 hasConcept C71924100 @default.
- W2921476261 hasConcept C78519656 @default.
- W2921476261 hasConceptScore W2921476261C126322002 @default.
- W2921476261 hasConceptScore W2921476261C127413603 @default.
- W2921476261 hasConceptScore W2921476261C164705383 @default.
- W2921476261 hasConceptScore W2921476261C207103383 @default.